RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
RegeneRx Biopharmaceuticals Stock

RegeneRx Biopharmaceuticals Market capitalization 2024

RegeneRx Biopharmaceuticals Market capitalization

2,009.7 USD

Ticker

RGRX

ISIN

US75886X1081

WKN

875295

In 2024, RegeneRx Biopharmaceuticals's market cap stood at 2,009.7 USD, a -99.99% increase from the 17.16 M USD market cap in the previous year.

The RegeneRx Biopharmaceuticals Market capitalization history

YEARMarket Capitalization (undefined USD)
20220
20210.04
20200.05
20192.14
20182.36
20173.42
20165.57
20153.71
20141.56

RegeneRx Biopharmaceuticals Aktienanalyse

What does RegeneRx Biopharmaceuticals do?

RegeneRx Biopharmaceuticals Inc is a biotechnology company focused on the development and commercialization of drugs for the treatment of diseases. The company is headquartered in Rockville, Maryland and was founded in 1982. Since its inception, RegeneRx has brought various products to market and is known for its research in tissue regeneration. The company started its early years with research in the field of nerve regeneration. As a result of this research, RegeneRx developed its first chemical called Thymosin beta 4 (Tβ4). Tβ4 is a naturally occurring protein produced in the human body. It serves as a growth factor for cells and plays an important role in healing damaged tissue. RegeneRx used this knowledge and began intensive work on the growth of Tβ4 in the laboratory. The company's researchers soon realized that Tβ4 was not only important for nerve regeneration, but could also be used in skin damage, stroke, and heart attack treatment. The researchers continued to work on the substance and in 1999 successfully brought the so-called Eye Drop product A3G12 to the market. This product is used to treat eye injuries and infections. In the following years, RegeneRx continued to research Tβ4. It was found that Tβ4 could also be successfully used in COPD (Chronic Lung Problems), wound healing, and bone disorders. Various products were developed for this purpose, available under the names RGN-137, RGN-259, and RGN-352. RegeneRx has also formed partnerships with other pharmaceutical companies such as Axio Biosolutions and Gtree BNP, and has successfully collaborated with them. In early 2021, it was decided that RegeneRx would expand its expertise in the Asian market and signed an agreement with Gtree BNP. The two companies planned to market RegeneRx products RGN-503 and RGN-352 in South Korea. Overall, RegeneRx Biopharmaceuticals Inc. has developed an impressive list of products that have successfully undergone patent and regulatory processes. These products treat a variety of diseases and injuries. RegeneRx is committed to continuing its research in this field and developing new products to help improve the health and well-being of patients worldwide. The company's business model primarily focuses on research and development. It has expanded in recent years due to the high potential of Tβ4 and its use in many medical areas. RegeneRx expects that by expanding the use of Tβ4, there will be greater acceptance and demand for its products worldwide. RegeneRx Biopharmaceuticals Inc is a company operating in the field of regenerative medicine. The products are typically positioned in the higher price range, in line with the company's market positioning. The company has successfully collaborated with other pharmaceutical companies in the past and is expected to form further alliances. RegeneRx sees itself as a leading biotechnology company focused on innovative drugs. RegeneRx Biopharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring RegeneRx Biopharmaceuticals's Market Capitalization

RegeneRx Biopharmaceuticals's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of RegeneRx Biopharmaceuticals's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

RegeneRx Biopharmaceuticals's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in RegeneRx Biopharmaceuticals’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about RegeneRx Biopharmaceuticals stock

What is the current RegeneRx Biopharmaceuticals market capitalization?

The current market capitalization of RegeneRx Biopharmaceuticals is 2,009.7 USD.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like RegeneRx Biopharmaceuticals.

How has the market capitalization of RegeneRx Biopharmaceuticals developed in recent years?

The market capitalization of RegeneRx Biopharmaceuticals has increased/decreased by -99.99% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of RegeneRx Biopharmaceuticals?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of RegeneRx Biopharmaceuticals?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of RegeneRx Biopharmaceuticals have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does RegeneRx Biopharmaceuticals pay?

Over the past 12 months, RegeneRx Biopharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, RegeneRx Biopharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of RegeneRx Biopharmaceuticals?

The current dividend yield of RegeneRx Biopharmaceuticals is .

When does RegeneRx Biopharmaceuticals pay dividends?

RegeneRx Biopharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of RegeneRx Biopharmaceuticals?

RegeneRx Biopharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of RegeneRx Biopharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is RegeneRx Biopharmaceuticals located?

RegeneRx Biopharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von RegeneRx Biopharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of RegeneRx Biopharmaceuticals from 10/7/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/7/2024.

When did RegeneRx Biopharmaceuticals pay the last dividend?

The last dividend was paid out on 10/7/2024.

What was the dividend of RegeneRx Biopharmaceuticals in the year 2023?

In the year 2023, RegeneRx Biopharmaceuticals distributed 0 USD as dividends.

In which currency does RegeneRx Biopharmaceuticals pay out the dividend?

The dividends of RegeneRx Biopharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von RegeneRx Biopharmaceuticals

Our stock analysis for RegeneRx Biopharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of RegeneRx Biopharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.